Share Price and Basic Stock Data
Last Updated: March 7, 2025, 12:01 pm
PEG Ratio | 0.83 |
---|
Competitors of Mohini Health & Hygiene Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Constronics Infra Ltd | 110 Cr. | 87.7 | 158/35.8 | 39.8 | 22.9 | 0.00 % | 20.8 % | 118 % | 10.0 |
Centenial Surgical Suture Ltd | 36.1 Cr. | 99.0 | 170/82.8 | 89.5 | 0.00 % | 8.07 % | 3.57 % | 10.0 | |
Adeshwar Meditex Ltd | 23.8 Cr. | 16.5 | 36.0/15.3 | 10.9 | 24.8 | 0.00 % | 9.62 % | 5.93 % | 10.0 |
Poly Medicure Ltd | 23,800 Cr. | 2,349 | 3,358/1,373 | 75.5 | 256 | 0.13 % | 23.6 % | 19.1 % | 5.00 |
Mohini Health & Hygiene Ltd | 113 Cr. | 61.9 | 86.9/46.0 | 10.8 | 57.2 | 0.81 % | 14.5 % | 11.1 % | 10.0 |
Industry Average | 8,007.67 Cr | 522.82 | 34.25 | 90.08 | 0.19% | 15.32% | 31.54% | 9.00 |
Quarterly Result
Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 59 | 62 | 66 | 72 | 63 | 46 | 82 | 99 | 93 | 101 | 98 | 91 |
Expenses | 48 | 54 | 63 | 60 | 59 | 40 | 78 | 94 | 85 | 94 | 92 | 82 |
Operating Profit | 10 | 8 | 3 | 12 | 5 | 6 | 4 | 5 | 7 | 8 | 6 | 9 |
OPM % | 18% | 13% | 4% | 17% | 7% | 13% | 4% | 5% | 8% | 8% | 6% | 10% |
Other Income | 0 | 0 | 6 | 0 | 0 | 1 | 6 | 6 | 0 | 4 | 4 | 1 |
Interest | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 |
Depreciation | 3 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Profit before tax | 5 | 4 | 4 | 7 | 0 | 2 | 6 | 8 | 3 | 7 | 6 | 7 |
Tax % | 0% | 5% | 31% | 0% | 3,780% | 25% | 31% | 32% | 46% | 28% | 10% | 30% |
Net Profit | 5 | 4 | 3 | 7 | -2 | 2 | 4 | 5 | 2 | 5 | 6 | 5 |
EPS in Rs | 2.74 | 1.99 | 1.48 | 4.10 | -1.01 | 0.90 | 2.09 | 2.81 | 0.91 | 2.83 | 3.07 | 2.64 |
Last Updated: February 28, 2025, 6:22 pm
Below is a detailed analysis of the quarterly data for Mohini Health & Hygiene Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Sales, as of Sep 2024, the value is ₹91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 98.00 Cr. (Mar 2024) to ₹91.00 Cr., marking a decrease of 7.00 Cr..
- For Expenses, as of Sep 2024, the value is ₹82.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 92.00 Cr. (Mar 2024) to ₹82.00 Cr., marking a decrease of 10.00 Cr..
- For Operating Profit, as of Sep 2024, the value is ₹9.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to ₹9.00 Cr., marking an increase of ₹3.00 Cr..
- For OPM %, as of Sep 2024, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Mar 2024) to 10.00%, marking an increase of 4.00%.
- For Other Income, as of Sep 2024, the value is ₹1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to ₹1.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Sep 2024, the value is ₹1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2024) to ₹1.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Profit before tax, as of Sep 2024, the value is ₹7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to ₹7.00 Cr., marking an increase of ₹1.00 Cr..
- For Tax %, as of Sep 2024, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 10.00% (Mar 2024) to 30.00%, marking an increase of 20.00%.
- For Net Profit, as of Sep 2024, the value is ₹5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to ₹5.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Sep 2024, the value is 2.64. The value appears to be declining and may need further review. It has decreased from ₹3.07 (Mar 2024) to 2.64, marking a decrease of ₹0.43.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 3:28 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 41 | 49 | 91 | 122 | 137 | 148 | 127 | 128 | 135 | 127 | 192 | 200 | 190 |
Expenses | 39 | 47 | 86 | 112 | 127 | 130 | 107 | 117 | 118 | 118 | 179 | 186 | 174 |
Operating Profit | 2 | 2 | 5 | 10 | 10 | 17 | 20 | 11 | 17 | 9 | 13 | 14 | 15 |
OPM % | 5% | 4% | 5% | 8% | 7% | 12% | 16% | 8% | 12% | 7% | 7% | 7% | 8% |
Other Income | -0 | 0 | 0 | 1 | 3 | 2 | 1 | 6 | 0 | 7 | 6 | 8 | 6 |
Interest | 1 | 1 | 1 | 4 | 3 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 4 |
Depreciation | 0 | 0 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 |
Profit before tax | 1 | 1 | 3 | 4 | 8 | 7 | 10 | 8 | 8 | 8 | 11 | 13 | 13 |
Tax % | 28% | 32% | 24% | 10% | 27% | 30% | 26% | 18% | 25% | 29% | 36% | 20% | |
Net Profit | 1 | 1 | 2 | 4 | 6 | 5 | 8 | 6 | 6 | 5 | 7 | 11 | 10 |
EPS in Rs | 5.52 | 2.88 | 7.62 | 15.03 | 18.83 | 2.81 | 4.21 | 3.46 | 3.09 | 2.99 | 3.72 | 5.89 | 5.71 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 8% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 0.00% | 100.00% | 100.00% | 50.00% | -16.67% | 60.00% | -25.00% | 0.00% | -16.67% | 40.00% | 57.14% |
Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | 0.00% | -50.00% | -66.67% | 76.67% | -85.00% | 25.00% | -16.67% | 56.67% | 17.14% |
Mohini Health & Hygiene Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 10% |
3 Years: | 14% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 31% |
5 Years: | 7% |
3 Years: | 23% |
TTM: | 53% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 34% |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 9% |
3 Years: | 9% |
Last Year: | 11% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 8:31 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1 | 3 | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Reserves | 3 | 10 | 12 | 16 | 21 | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 86 |
Borrowings | 7 | 23 | 52 | 58 | 65 | 56 | 51 | 42 | 43 | 44 | 28 | 23 | 26 |
Other Liabilities | 2 | 5 | 18 | 11 | 18 | 20 | 16 | 19 | 22 | 22 | 21 | 17 | 35 |
Total Liabilities | 14 | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 166 |
Fixed Assets | 6 | 6 | 44 | 42 | 41 | 64 | 63 | 60 | 64 | 50 | 49 | 40 | 38 |
CWIP | 0 | 18 | 0 | 1 | 21 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
Other Assets | 8 | 17 | 40 | 44 | 44 | 70 | 70 | 72 | 79 | 98 | 89 | 98 | 126 |
Total Assets | 14 | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 166 |
Below is a detailed analysis of the balance sheet data for Mohini Health & Hygiene Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹18.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹86.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹82.00 Cr. (Mar 2024) to ₹86.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹26.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹23.00 Cr. (Mar 2024) to ₹26.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹35.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹17.00 Cr. (Mar 2024) to ₹35.00 Cr., marking an increase of 18.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹166.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹140.00 Cr. (Mar 2024) to ₹166.00 Cr., marking an increase of 26.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹38.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹40.00 Cr. (Mar 2024) to ₹38.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹1.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹0.00 Cr. (Mar 2024) to ₹1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹2.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹126.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹98.00 Cr. (Mar 2024) to ₹126.00 Cr., marking an increase of 28.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹166.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹140.00 Cr. (Mar 2024) to ₹166.00 Cr., marking an increase of 26.00 Cr..
Notably, the Reserves (₹86.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -5.00 | -21.00 | -47.00 | -48.00 | -55.00 | -39.00 | -31.00 | -31.00 | -26.00 | -35.00 | -15.00 | -9.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 36 | 26 | 133 | 49 | 64 | 89 | 82 | 65 | 60 | 112 | 67 | |
Inventory Days | 9 | 52 | 15 | 58 | 37 | 44 | 79 | 94 | 126 | 106 | 65 | |
Days Payable | 8 | 13 | 44 | 14 | 13 | 15 | 16 | 28 | 25 | 18 | 16 | |
Cash Conversion Cycle | 36 | 65 | 105 | 93 | 88 | 117 | 145 | 131 | 161 | 200 | 116 | |
Working Capital Days | 44 | 72 | 102 | 104 | 71 | 104 | 138 | 132 | 151 | 221 | 134 | |
ROCE % | 19% | 8% | 6% | 12% | 13% | 14% | 14% | 10% | 10% | 9% | 12% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 5.86 | 3.72 | 3.71 | 3.25 | 3.58 |
Diluted EPS (Rs.) | 5.86 | 3.72 | 3.71 | 3.25 | 3.58 |
Cash EPS (Rs.) | 8.22 | 6.07 | 6.78 | 6.39 | 6.37 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 55.05 | 49.19 | 46.03 | 42.70 | 39.57 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 55.05 | 49.19 | 46.03 | 42.70 | 39.57 |
Revenue From Operations / Share (Rs.) | 109.46 | 105.29 | 77.94 | 75.39 | 71.11 |
PBDIT / Share (Rs.) | 12.00 | 10.44 | 9.59 | 9.90 | 9.36 |
PBIT / Share (Rs.) | 9.64 | 8.10 | 6.69 | 6.90 | 6.58 |
PBT / Share (Rs.) | 7.31 | 5.82 | 4.77 | 4.54 | 4.24 |
Net Profit / Share (Rs.) | 5.86 | 3.72 | 3.89 | 3.39 | 3.58 |
NP After MI And SOA / Share (Rs.) | 5.86 | 3.72 | 3.71 | 3.25 | 3.58 |
PBDIT Margin (%) | 10.96 | 9.91 | 12.30 | 13.13 | 13.16 |
PBIT Margin (%) | 8.80 | 7.69 | 8.58 | 9.14 | 9.24 |
PBT Margin (%) | 6.68 | 5.53 | 6.12 | 6.02 | 5.95 |
Net Profit Margin (%) | 5.35 | 3.53 | 4.98 | 4.49 | 5.03 |
NP After MI And SOA Margin (%) | 5.35 | 3.53 | 4.76 | 4.30 | 5.03 |
Return on Networth / Equity (%) | 10.64 | 7.56 | 8.12 | 7.63 | 9.04 |
Return on Capital Employeed (%) | 15.83 | 14.35 | 13.05 | 13.42 | 13.51 |
Return On Assets (%) | 7.65 | 4.90 | 4.30 | 4.03 | 4.87 |
Long Term Debt / Equity (X) | 0.05 | 0.09 | 0.06 | 0.15 | 0.18 |
Total Debt / Equity (X) | 0.22 | 0.31 | 0.52 | 0.46 | 0.48 |
Asset Turnover Ratio (%) | 1.44 | 1.30 | 0.93 | 0.98 | 0.97 |
Current Ratio (X) | 3.19 | 2.43 | 1.57 | 1.47 | 1.54 |
Quick Ratio (X) | 2.41 | 1.73 | 1.15 | 0.89 | 1.01 |
Inventory Turnover Ratio (X) | 6.25 | 5.42 | 3.42 | 3.11 | 4.32 |
Interest Coverage Ratio (X) | 5.16 | 4.59 | 4.99 | 4.21 | 4.00 |
Interest Coverage Ratio (Post Tax) (X) | 3.52 | 2.64 | 3.02 | 2.44 | 2.53 |
Enterprise Value (Cr.) | 113.80 | 119.96 | 93.74 | 79.60 | 54.34 |
EV / Net Operating Revenue (X) | 0.57 | 0.62 | 0.65 | 0.57 | 0.41 |
EV / EBITDA (X) | 5.20 | 6.30 | 5.36 | 4.41 | 3.18 |
MarketCap / Net Operating Revenue (X) | 0.48 | 0.48 | 0.35 | 0.32 | 0.16 |
Price / BV (X) | 0.95 | 1.03 | 0.60 | 0.56 | 0.28 |
Price / Net Operating Revenue (X) | 0.48 | 0.48 | 0.35 | 0.32 | 0.16 |
EarningsYield | 0.11 | 0.07 | 0.13 | 0.13 | 0.31 |
After reviewing the key financial ratios for Mohini Health & Hygiene Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For Diluted EPS (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For Cash EPS (Rs.), as of Mar 24, the value is 8.22. This value is within the healthy range. It has increased from 6.07 (Mar 23) to 8.22, marking an increase of 2.15.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 55.05. It has increased from 49.19 (Mar 23) to 55.05, marking an increase of 5.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 55.05. It has increased from 49.19 (Mar 23) to 55.05, marking an increase of 5.86.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 109.46. It has increased from 105.29 (Mar 23) to 109.46, marking an increase of 4.17.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 12.00. This value is within the healthy range. It has increased from 10.44 (Mar 23) to 12.00, marking an increase of 1.56.
- For PBIT / Share (Rs.), as of Mar 24, the value is 9.64. This value is within the healthy range. It has increased from 8.10 (Mar 23) to 9.64, marking an increase of 1.54.
- For PBT / Share (Rs.), as of Mar 24, the value is 7.31. This value is within the healthy range. It has increased from 5.82 (Mar 23) to 7.31, marking an increase of 1.49.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For PBDIT Margin (%), as of Mar 24, the value is 10.96. This value is within the healthy range. It has increased from 9.91 (Mar 23) to 10.96, marking an increase of 1.05.
- For PBIT Margin (%), as of Mar 24, the value is 8.80. This value is below the healthy minimum of 10. It has increased from 7.69 (Mar 23) to 8.80, marking an increase of 1.11.
- For PBT Margin (%), as of Mar 24, the value is 6.68. This value is below the healthy minimum of 10. It has increased from 5.53 (Mar 23) to 6.68, marking an increase of 1.15.
- For Net Profit Margin (%), as of Mar 24, the value is 5.35. This value is within the healthy range. It has increased from 3.53 (Mar 23) to 5.35, marking an increase of 1.82.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.35. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 23) to 5.35, marking an increase of 1.82.
- For Return on Networth / Equity (%), as of Mar 24, the value is 10.64. This value is below the healthy minimum of 15. It has increased from 7.56 (Mar 23) to 10.64, marking an increase of 3.08.
- For Return on Capital Employeed (%), as of Mar 24, the value is 15.83. This value is within the healthy range. It has increased from 14.35 (Mar 23) to 15.83, marking an increase of 1.48.
- For Return On Assets (%), as of Mar 24, the value is 7.65. This value is within the healthy range. It has increased from 4.90 (Mar 23) to 7.65, marking an increase of 2.75.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.05, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.31 (Mar 23) to 0.22, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.44. It has increased from 1.30 (Mar 23) to 1.44, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 24, the value is 3.19. This value exceeds the healthy maximum of 3. It has increased from 2.43 (Mar 23) to 3.19, marking an increase of 0.76.
- For Quick Ratio (X), as of Mar 24, the value is 2.41. This value exceeds the healthy maximum of 2. It has increased from 1.73 (Mar 23) to 2.41, marking an increase of 0.68.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.25. This value is within the healthy range. It has increased from 5.42 (Mar 23) to 6.25, marking an increase of 0.83.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 5.16. This value is within the healthy range. It has increased from 4.59 (Mar 23) to 5.16, marking an increase of 0.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.52. This value is within the healthy range. It has increased from 2.64 (Mar 23) to 3.52, marking an increase of 0.88.
- For Enterprise Value (Cr.), as of Mar 24, the value is 113.80. It has decreased from 119.96 (Mar 23) to 113.80, marking a decrease of 6.16.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.62 (Mar 23) to 0.57, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 24, the value is 5.20. This value is within the healthy range. It has decreased from 6.30 (Mar 23) to 5.20, marking a decrease of 1.10.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.48. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.48.
- For Price / BV (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.03 (Mar 23) to 0.95, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.48. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.48.
- For EarningsYield, as of Mar 24, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 23) to 0.11, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mohini Health & Hygiene Ltd:
- Net Profit Margin: 5.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.83% (Industry Average ROCE: 15.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.64% (Industry Average ROE: 31.54%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.52
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.41
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.8 (Industry average Stock P/E: 27.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.35%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Medical Equipment & Accessories | Plot No 109, Sector 3, Dhar Madhya Pradesh 454774 | cs@mohinihealthandhygiene.com, http://www.mohinihealthandhygiene.com |
Management | |
---|---|
Name | Position Held |
Mr. Avnish Bansal | Managing Director |
Mr. Viral Patel | Executive Director |
Mr. Sarvapriya Bansal | Whole Time Director |
Mrs. Parul Agarwal | Whole Time Director |
Mr. Mukesh Vyas | Ind. Non-Executive Director |
Mr. Chandrashekhar Bobra | Ind. Non-Executive Director |
Mr. Mukul Jain | Ind. Non-Executive Director |
Mr. Mahesh Fogla | Ind. Non-Executive Director |
FAQ
What is the latest intrinsic value of Mohini Health & Hygiene Ltd?
The latest intrinsic value of Mohini Health & Hygiene Ltd as on 08 March 2025 is ₹55.30, which is 10.66% lower than the current market price of 61.90, indicating the stock is overvalued by 10.66%. The intrinsic value of Mohini Health & Hygiene Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹113 Cr. and recorded a high/low of ₹86.9/46.0 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹86 Cr and total liabilities of ₹166 Cr.
What is the Market Cap of Mohini Health & Hygiene Ltd?
The Market Cap of Mohini Health & Hygiene Ltd is 113 Cr..
What is the current Stock Price of Mohini Health & Hygiene Ltd as on 08 March 2025?
The current stock price of Mohini Health & Hygiene Ltd as on 08 March 2025 is ₹61.9.
What is the High / Low of Mohini Health & Hygiene Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Mohini Health & Hygiene Ltd stocks is ₹86.9/46.0.
What is the Stock P/E of Mohini Health & Hygiene Ltd?
The Stock P/E of Mohini Health & Hygiene Ltd is 10.8.
What is the Book Value of Mohini Health & Hygiene Ltd?
The Book Value of Mohini Health & Hygiene Ltd is 57.2.
What is the Dividend Yield of Mohini Health & Hygiene Ltd?
The Dividend Yield of Mohini Health & Hygiene Ltd is 0.81 %.
What is the ROCE of Mohini Health & Hygiene Ltd?
The ROCE of Mohini Health & Hygiene Ltd is 14.5 %.
What is the ROE of Mohini Health & Hygiene Ltd?
The ROE of Mohini Health & Hygiene Ltd is 11.1 %.
What is the Face Value of Mohini Health & Hygiene Ltd?
The Face Value of Mohini Health & Hygiene Ltd is 10.0.